| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.009 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.01 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |